Clinical studies have shown that immunomodulators (like Anti-CD3 antibodies) have effects on
beta-cell-preservation. The lipid-lowering agent atorvastatin is also a potent
immunomodulator. In this study the effects of 80 mg atorvastatin per day on preservation of
beta-cell function in recent onset type 1 diabetes were studied, as determined by stimulated
C-peptide levels.